Balance Sheet for Taro Pharmaceutical Industries Ltd. (TARO)

$ 67.45   -0.04 (-0.06%) Volume: 21.43k 7:00 PM EDT Jul 2, 2020
After Hours:  $ 67.45 0.00 (0.00%) Volume: 44 4:00 PM EDT Jul 2, 2020
Statement: View:
Assets [+] in Millions of Dollars
03/2020 03/2019 03/2018 03/2017 03/2016
Cash and Equivalents 513 567 577 600 577
Restrictable Cash - - - - -
Marketable Securities 595 482 846 786 652
Accounts Receivable 235 238 206 204 239
Loans Receivable - - - - -
Other Receivables 18 29 104 114 42
Receivables 262 277 322 326 284
Inventories, Raw Materials 50 45 56 53 48
Inventories, Work in Progress 34 33 27 27 27
Inventories, Purchased Components - - - - -
Inventories, Finished Goods 64 66 57 57 60
Inventories, Other 158 153 149 145 142
Inventories, Adjustments & Allowances - - - - -
Inventories 153 148 145 141 139
Prepaid Expenses 9 8 8 12 13
Current Deferred Income Taxes - - - 132 212
Other Current Assets - - - - -
Total Current Assets 1,533 1,483 1,897 1,999 1,878
Land and Improvements 8 8 8 8 8
Buildings and Improvement 191 186 174 161 153
Machinery, Furniture and Equipment 267 249 246 230 216
Construction in Progress - - - - -
Fixed Assets, Other 2 - - - -
Fixed Assets, Total 468 443 428 398 377
Gross Fixed Assets 468 443 428 398 377
Accumulated Depreciation (255) (236) (234) (218) (217)
Net Fixed Assets 212 206 194 180 159
Intangibles 8 9 7 6 8
Cost in Excess 7 7 7 7 7
Non-Current Deferred Income Taxes 107 111 87 10 4
Other Non-Current Assets 0 0 0 0 2
Total Non-Current Assets 809 653 537 291 310
Total Assets 2,341 2,135 2,433 2,290 2,188
Liabilities [+] in Millions of Dollars
03/2020 03/2019 03/2018 03/2017 03/2016
Accounts Payable 33 37 30 23 31
Short Term Debt 2 - - - 2
Notes Payable - - - - -
Accrued Expenses 36 37 37 33 36
Accrued Liabilities 36 37 37 33 36
Deferred Revenues 0 9 0 0 1
Current Deferred Income Taxes 8 12 56 74 (12)
Other Current Liabilities 152 133 148 153 175
Total Current Liabilities 223 217 216 210 245
Long Term Debt N/A N/A N/A N/A 9
Deferred Income Tax 3 3 3 2 2
Other Non-Current Liabilities 5 4 4 4 (6)
Minority Interest 6 6 5 6 6
Capital Lease Obligations - - - - -
Preferred Securities of Subsidiary Trust - - - - -
Preferred Equity Outside Shareholders' Equity - - - - -
Total Non-Current Liabilities 15 13 12 12 11
Total Liabilities 237 230 228 222 257
Preferred Shareholder's Equity - - - - -
Common Shareholder's Equity 2,104 1,906 2,205 2,067 1,931
Common Par 1 1 1 1 1
Additional Paid in Capital 262 262 262 262 262
Cumulative Translation Adjustments - - - - -
Retained Earnings 2,725 2,481 2,662 2,451 1,995
Treasury Stock 721 695 610 499 204
Other Equity Adjustments (163) (144) (110) (148) (123)
Total Capitalization 2,104 1,906 2,205 2,067 1,940
Total Equity 2,104 1,906 2,205 2,067 1,931
Total Liabilities & Shareholder's Equity 2,341 2,135 2,433 2,290 2,188
Cash Flow 245 282 210 457 541
Working Capital 1,310 1,266 1,681 1,789 1,632
Free Cash Flow 243 293 294 402 376
Invested Capital 2,104 1,906 2,205 2,067 1,931
Shares Outstanding - Common Class Only 38 39 39 41 43
Preferred Shares Outstanding - - - - -
Total Ordinary Shares 38 39 39 41 43
Total Common Shares Outstanding 38 39 39 41 43
Treasury Shares 7 7 6 5 2
Basic Weighted Shares Outstanding 38 39 40 41 43
Diluted Weighted Shares Outstanding 38 39 40 41 43